Preferential production of IgG2 antibodies by parenchymal lung B-lymphocytes during lung allograft rejection.
Wilkes
D S
DS
Department of Medicine, Indiana University School of Medicine, Indianapolis 46202, USA.
Sidner
R A
RA
Mathur
P N
PN
Niemeier
M
M
Schwenk
R
R
Heidler
K M
KM
Bowen
L K
LK
D000917:Antibody Formation; D015703:Antigens, CD / Q000032:analysis; D018951:Antigens, CD20 / Q000032:analysis; D001402:B-Lymphocytes / Q000276:immunology* / Q000473:pathology; D001706:Biopsy; D001989:Bronchiolitis Obliterans / Q000276:immunology / Q000473:pathology*; D015704:CD4 Antigens / Q000032:analysis; D016827:CD8 Antigens / Q000032:analysis; D002478:Cells, Cultured; D003937:Diagnosis, Differential; D006084:Graft Rejection / Q000276:immunology* / Q000473:pathology*; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis* / Q000145:classification; D016040:Lung Transplantation / Q000276:immunology* / Q000473:pathology; D011183:Postoperative Complications; D014184:Transplantation, Homologous
D015703:Antigens, CD; D018951:Antigens, CD20; D015704:CD4 Antigens; D016827:CD8 Antigens; D007074:Immunoglobulin G